Moira Rynn, MD


Associate Professor of Clinical Psychiatry, New York State Psychiatric Institute/Columbia University

1051 Riverside Drive, Unit 78
New York, New York 10032

Narrative of Services:

Dr. Moira Rynn is Director of the Children's Day Unit and the Child and Adolescent Psychiatric Evaluation Service NYSPI and CU. Dr. Rynn provides expert psychopharmacological treatment and consultation as part of the CDU. The CDU is an outpatient day program that provides services for the psychiatric, educational, and social support needs of clients (children and adolescents) who require intensive treatment for mood and anxiety disorders. A significant proportion of children treated are diagnosed with OC related disorders, often who have not responded to first line available treatments. Children receive a comprehensive evaluation with psychopharmacological and psychosocial consultation. The team consists of a medical director, nurse, social worker, cognitive behavioral psychologist. For children who are unable to attend school, the CDU provides school services by PS186X, a New York City public school located on the unit during the academic year from September through June.

Training Description:

Dr. Moira Rynn is Deputy Director of Research in the Division of Child and Adolescent Psychiatry. Previously she had been the Medical Director of the Mood and Anxiety Disorders Section of the Department of Psychiatry at the University of Pennsylvania School of Medicine (PENN) since 1998. Dr. Rynn joined the Department of Psychiatry at PENN in 1991 as a resident and during her last year of residency served as Chief Resident. In 1997, she completed the Child and Adolescent Psychiatry Fellowship at the Children's Hospital of Philadelphia, Child Guidance Center, followed by a Neuropsychopharmacology Research Fellowship, sponsored by the NIMH at PENN. Dr. Rynn's area of research has been focused on pediatric psychopharmacology with an emphasis on anxiety disorders, specifically general anxiety disorder and OCD. At PENN, Dr. Rynn participated as an investigator in the Pediatric OCD Treatment Study (POTS) Team (JAMA, 2004). Presently, at NYSPI/CU, she is working on examining the efficacy of novel compounds for the treatment of pediatric OCD. Dr. Rynn has been providing pharmacologic treatment for adults and children diagnosed with OCD since 1991.